169 related articles for article (PubMed ID: 11313272)
1. Cytokine-regulated expression of survivin in myeloid leukemia.
Carter BZ; Milella M; Altieri DC; Andreeff M
Blood; 2001 May; 97(9):2784-90. PubMed ID: 11313272
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Estrov Z
Blood; 2003 Jul; 102(2):630-7. PubMed ID: 12663443
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
[TBL] [Abstract][Full Text] [Related]
4. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
Lisovsky M; Estrov Z; Zhang X; Consoli U; Sanchez-Williams G; Snell V; Munker R; Goodacre A; Savchenko V; Andreeff M
Blood; 1996 Nov; 88(10):3987-97. PubMed ID: 8916965
[TBL] [Abstract][Full Text] [Related]
5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
6. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia.
Carter BZ; Milella M; Tsao T; McQueen T; Schober WD; Hu W; Dean NM; Steelman L; McCubrey JA; Andreeff M
Leukemia; 2003 Nov; 17(11):2081-9. PubMed ID: 12970762
[TBL] [Abstract][Full Text] [Related]
7. Expression of the antiapoptosis gene survivin in human leukemia.
Mori A; Wada H; Nishimura Y; Okamoto T; Takemoto Y; Kakishita E
Int J Hematol; 2002 Feb; 75(2):161-5. PubMed ID: 11939262
[TBL] [Abstract][Full Text] [Related]
8. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.
Hu H; Shikama Y; Matsuoka I; Kimura J
J Leukoc Biol; 2008 Feb; 83(2):393-400. PubMed ID: 17965335
[TBL] [Abstract][Full Text] [Related]
9. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells.
Fukuda S; Foster RG; Porter SB; Pelus LM
Blood; 2002 Oct; 100(7):2463-71. PubMed ID: 12239157
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
[TBL] [Abstract][Full Text] [Related]
11. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.
Carter BZ; Kornblau SM; Tsao T; Wang RY; Schober WD; Milella M; Sung HG; Reed JC; Andreeff M
Blood; 2003 Dec; 102(12):4179-86. PubMed ID: 12920030
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.
Fukuda S; Pelus LM
Blood; 2001 Oct; 98(7):2091-100. PubMed ID: 11567995
[TBL] [Abstract][Full Text] [Related]
13. [Factors regulating expression of antiapoptosis gene survivin].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):969-74. PubMed ID: 16403261
[TBL] [Abstract][Full Text] [Related]
14. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
Sugahara K; Uemura A; Harasawa H; Nagai H; Hirakata Y; Tomonaga M; Murata K; Sohda H; Nakagoe T; Shibasaki S; Yamada Y; Kamihira S
Int J Hematol; 2004 Jul; 80(1):52-8. PubMed ID: 15293568
[TBL] [Abstract][Full Text] [Related]
16. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
17. [Expression of survivin in leukemia cells and influence on it by GM-CSF].
Wu YH; Zou P; Liu F; Shen HB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):6-9. PubMed ID: 17490510
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
Zhu N; Gu L; Li F; Zhou M
Mol Cancer Ther; 2008 May; 7(5):1101-9. PubMed ID: 18483299
[TBL] [Abstract][Full Text] [Related]
19. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
20. Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitro.
Braun S; Gerhartz HH; Schmetzer HM
Ann Hematol; 2000 Jul; 79(7):363-73. PubMed ID: 10965784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
